15
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Reliability, Validity, Modification and Expansion of the Chinese Version of the Disease-Specific Anxiety Questionnaire for Chronic Obstructive Pulmonary Disease

, ORCID Icon, , , , & show all
Pages 1047-1060 | Received 15 Dec 2023, Accepted 07 May 2024, Published online: 13 May 2024

References

  • World Health Organization. Top 10 causes of death. World Health Organization; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed May 8, 2024.
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Murray CJL. The global burden of disease study at 30 years. Nat Med. 2022;28(10):2019–2026. doi:10.1038/s41591-022-01990-1
  • Adeloye D, Song P, Zhu Y, et al. NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
  • Gordon CS, Waller JW, Cook RM, et al. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156(1):80–91. doi:10.1016/j.chest.2019.04.009
  • Feng L, Li J, Lv X, et al. Temporal trends in anxiety and depression prevalence and their association with adverse outcomes in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease in Beijing, China, from 2004 to 2020. Front Psychiatry. 2022;13:996451. doi:10.3389/fpsyt.2022.996451
  • Wu D, Zhao X, Huang D, et al. Outcomes associated with comorbid anxiety and depression among patients with stable COPD: a patient registry study in China. J Affect Disord. 2022;313:77–83. doi:10.1016/j.jad.2022.06.059
  • Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667–677. doi:10.1183/09031936.00125707
  • Ivziku D, Clari M, Piredda M, et al. Anxiety, depression and quality of life in chronic obstructive pulmonary disease patients and caregivers: an actor-partner interdependence model analysis. Qual Life Res. 2019;28(2):461–472. doi:10.1007/s11136-018-2024-z
  • Heslop-Marshall K, Baker C, Carrick-Sen D, et al. Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res. 2018;4(4):00094–2018. doi:10.1183/23120541.00094-2018
  • Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11–S18. doi:10.3949/ccjm.85.s1.03
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–379. doi:10.1016/S0033-3182(71)71479-0
  • Liu M, Wang D, Fang J, et al. Validation of the generalized anxiety disorder-7 in patients with COPD: a cross-sectional study. BMC Psychiatry. 2023;23(1):593. doi:10.1186/s12888-023-05072-5
  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092
  • Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897. doi:10.1037//0022-006x.56.6.893
  • Baker AM, Holbrook JT, Yohannes AM, et al. American lung association airways clinical research centers. test performance characteristics of the AIR, GAD-7, and hads-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):926–934. doi:10.1513/AnnalsATS.201708-631OC
  • Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011;140(3):618–625. doi:10.1378/chest.10-3257
  • Willgoss TG, Goldbart J, Fatoye F, et al. The development and validation of the anxiety inventory for respiratory disease. Chest. 2013;144(5):1587–1596. doi:10.1378/chest.13-0168
  • Dong XY, Wang L, Tao YX, et al. Psychometric properties of the anxiety inventory for respiratory disease in patients with COPD in China. Int J Chron Obstruct Pulmon Dis. 2016;12:49–58. doi:10.2147/COPD.S117626
  • Zhang YH. Development of Specific Anxiety Scale for Patients with Chronic Obstructive Pulmonary Disease and Preliminary Application. JiangSu: JiangSu University; 2022.
  • Kühl K, Kuhn C, Kenn K, Rief W. Der COPD-Angst-Fragebogen (CAF): ein neues Instrument zur Erfassung krankheitsspezifischer Ängste bei COPD-Patienten [The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients]. Psychother Psychosom Med Psychol. 2011;61(1):e1–e9. German. doi:10.1055/s-0030-1248281
  • Keil DC, Stenzel NM, Kühl K, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11(1):31–40. doi:10.1177/1479972313516881
  • Reijnders T, Schuler M, Wittmann M, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respir Med. 2019;146:87–95. doi:10.1016/j.rmed.2018.12.004
  • Janssens T, Van de Moortel Z, Geidl W, et al. Impact of disease-specific fears on pulmonary rehabilitation trajectories in patients with COPD. J Clin Med. 2019;8(9):1460. doi:10.3390/jcm8091460
  • Farver-Vestergaard I, Rubio-Rask S, Timm S, et al. Disease-specific anxiety in chronic obstructive pulmonary disease: translation and initial validation of a questionnaire. Front Psychol. 2022;13:907939. doi:10.3389/fpsyg.2022.907939
  • Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 Report: GOLD executive summary. Eur Respir J. 2023;61(4):2300239. doi:10.1183/13993003.00239-2023
  • First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013;201(9):727–729. doi:10.1097/NMD.0b013e3182a2168a
  • Jones PS, Lee JW, Phillips LR, et al. An adaptation of Brislin’s translation model for cross-cultural research. Nurs Res. 2001;50(5):300–304. doi:10.1097/00006199-200109000-00008
  • Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. doi:10.1097/00007632-200012150-00014
  • Wang XD, Wang XL, Ma H. Rating scales for mental health(a revised and enlarged edition). Chin Ment Health J. 1999;1999:1.
  • Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974;34(3):1184–1186. doi:10.1177/003329417403403s01
  • Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi:10.1001/archpsyc.1961.01710120031004
  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.580
  • Donders AR, van der Heijden GJ, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–1091. doi:10.1016/j.jclinepi.2006.01.014
  • de Winter JC, Dodou D, Wieringa PA. Exploratory factor analysis with small sample sizes. Multivariate Behav Res. 2009;44(2):147–181. doi:10.1080/00273170902794206
  • Ferketich S. Focus on psychometrics. Aspects of item analysis. Res Nurs Health. 1991;14(2):165–168. doi:10.1002/nur.4770140211
  • Rosellini AJ, Brown TA. Developing and Validating Clinical Questionnaires. Annu Rev Clin Psychol. 2021;17:55–81. doi:10.1146/annurev-clinpsy-081219-115343
  • Streiner DL, Norman RG. Health Measurement Scales: A Practical Guide to Their Development and Use. 3rd ed. Oxford: Oxford University Press; 2003.
  • Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–467. doi:10.1002/nur.20199
  • Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39:31–36. doi:10.1007/BF02291575
  • Bartlett MS. The effect of standardization on a Chi-square approximation in factor analysis. Biometrika. 1951;337–344.
  • Groskurth K, Bluemke M, Lechner CM. Why we need to abandon fixed cutoffs for goodness-of-fit indices: an extensive simulation and possible solutions. Behav Res Methods. 2023. doi:10.3758/s13428-023-02193-3
  • Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959;56(2):81–105. doi:10.1037/h0046016
  • Castanho MJ, Barros LC, Yamakami A, et al. Fuzzy receiver operating characteristic curve: an option to evaluate diagnostic tests. IEEE Trans Inf Technol Biomed. 2007;11(3):244–250. doi:10.1109/titb.2006.879593
  • Verbakel JY, Steyerberg EW, Uno H, et al. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models. J Clin Epidemiol. 2020;126:207–216. doi:10.1016/j.jclinepi.2020.01.028
  • Marsh HW, Morin AJ, Parker PD, et al. Exploratory structural equation modeling: an integration of the best features of exploratory and confirmatory factor analysis. Annu Rev Clin Psychol. 2014;10:85–110. doi:10.1146/annurev-clinpsy-032813-153700